{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:54:24Z","timestamp":1790891664439,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011033","name":"State Agency of Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.nbd.2026.107506","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:10:51Z","timestamp":1782774651000},"page":"107506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Leveraging the dominant-negative effect of the kuru-protective G127V prion protein variant as a novel therapeutic strategy"],"prefix":"10.1016","volume":"227","author":[{"given":"Jean R.P.","family":"Gatdula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia A.","family":"Mirza-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel C.","family":"Orbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linnea M.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha G.","family":"Tolton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle S.","family":"Vultaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.C.","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Bartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn C.","family":"Telling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasier","family":"Era\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Castilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2026.107506_bb0005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/jnc.15739","article-title":"A single protective polymorphism in the prion protein blocks cross-species prion replication in cultured cells","volume":"165","author":"Arshad","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2026.107506_bb0010","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nature14510","article-title":"A naturally occurring variant of the human prion protein completely prevents prion disease","volume":"522","author":"Asante","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2026.107506_bb0015","article-title":"Metabotropic glutamate receptors transduce signals for neurite outgrowth after binding of the prion protein to laminin \u03b31 chain","volume":"25","author":"Beraldo","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2026.107506_bb0020","doi-asserted-by":"crossref","first-page":"8322","DOI":"10.1128\/JVI.00633-10","article-title":"Cell-based quantification of chronic wasting disease prions","volume":"84","author":"Bian","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2026.107506_bb0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00441-022-03665-2","article-title":"Prion strains: shining new light on old concepts","volume":"392","author":"Block","year":"2023","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.nbd.2026.107506_bb0030","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1074\/jbc.RA118.007135","article-title":"Engineering a murine cell line for the stable propagation of hamster prions","volume":"294","author":"Bourkas","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2026.107506_bb0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s004240100523","article-title":"Dose-dependent, prion protein (PrP)-mediated facilitation of excitatory synaptic transmission in the mouse hippocampus","volume":"442","author":"Carleton","year":"2001","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.nbd.2026.107506_bb0040","article-title":"Zinc finger repressors mediate widespread PRNP lowering in the nonhuman primate brain and profoundly extend survival in prion disease mice","author":"Chou","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.nbd.2026.107506_bb0045","first-page":"1375","article-title":"Cellular prion protein ablation impairs behavior as a function of age","volume":"14","author":"Coitinho","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2026.107506_bb0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/370295a0","article-title":"Prion protein is necessary for normal synaptic function","volume":"370","author":"Collinge","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2026.107506_bb0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00894-004-0213-x","article-title":"Tetracycline and its analogues as inhibitors of amyloid fibrils: searching for a geometrical pharmacophore by theoretical investigation of their conformational behavior in aqueous solution","volume":"11","author":"Cosentino","year":"2005","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.nbd.2026.107506_bb0060","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.nbd.2005.01.001","article-title":"Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons","volume":"19","author":"Criado","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2026.107506_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001888","article-title":"The efficacy of tetracyclines in peripheral and intracerebral prion infection","volume":"3","author":"De Luigi","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2026.107506_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-46360-2","article-title":"A protein misfolding shaking amplification-based method for the spontaneous generation of hundreds of bona fide prions","volume":"15","author":"Era\u00f1a","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2026.107506_bb0075","doi-asserted-by":"crossref","first-page":"10849","DOI":"10.1073\/pnas.162195499","article-title":"Tetracyclines affect prion infectivity","volume":"99","author":"Forloni","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2026.107506_bb0080","doi-asserted-by":"crossref","first-page":"5.23. 1","DOI":"10.1002\/0471140864.ps0523s56","article-title":"Autoinduction of protein expression","volume":"56","author":"Fox","year":"2009","journal-title":"Curr. Protoc. Protein Sci."},{"key":"10.1016\/j.nbd.2026.107506_bb0085","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0169-328X(95)00034-P","article-title":"New variant prion protein in a Japanese family with Gerstmann-Straussler syndrome","volume":"30","author":"Furukawa","year":"1995","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2026.107506_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013911","article-title":"Membrane-anchored PrPSc is the trigger for prion synaptotoxicity","volume":"22","author":"Gatdula","year":"2026","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.nbd.2026.107506_bb0095","doi-asserted-by":"crossref","first-page":"17971","DOI":"10.1073\/pnas.0708372104","article-title":"Cell division modulates prion accumulation in cultured cells","volume":"104","author":"Ghaemmaghami","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2026.107506_bb0100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(13)70307-7","article-title":"Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"13","author":"Ha\u00efk","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2026.107506_bb0105","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/JVI.72.2.1153-1159.1998","article-title":"Overexpression of nonconvertible PrP c \u0394114\u2013121 in scrapie-infected mouse neuroblastoma cells leads to trans-dominant inhibition of wild-type PrP Sc accumulation","volume":"72","author":"H\u00f6lscher","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2026.107506_bb0110","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-020-01126-6","article-title":"Structural effects of the highly protective V127 polymorphism on human prion protein","volume":"3","author":"Hosszu","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.nbd.2026.107506_bb0115","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jmb.2019.11.020","article-title":"Neutralizing mutations significantly inhibit amyloid formation by human prion protein and decrease its cytotoxicity","volume":"432","author":"Huang","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.nbd.2026.107506_bb0120","doi-asserted-by":"crossref","first-page":"10800","DOI":"10.1038\/s41598-020-67505-5","article-title":"Global analysis of protein degradation in prion infected cells","volume":"10","author":"Hutti","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2026.107506_bb0125","doi-asserted-by":"crossref","first-page":"10069","DOI":"10.1073\/pnas.94.19.10069","article-title":"Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation","volume":"94","author":"Kaneko","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2026.107506_bb0130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/13506120410001689634","article-title":"Non-glycosylphosphatidylinositol (GPI)-anchored recombinant prion protein with dominant-negative mutation inhibits PrPSc replication in vitro","volume":"11","author":"Kishida","year":"2004","journal-title":"Amyloid"},{"key":"10.1016\/j.nbd.2026.107506_bb0135","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1110\/ps.072954607","article-title":"The dominant-negative effect of the Q218K variant of the prion protein does not require protein X","volume":"16","author":"Lee","year":"2007","journal-title":"Protein Sci."},{"key":"10.1016\/j.nbd.2026.107506_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108223","article-title":"A tetracationic porphyrin with dual anti-prion activity","volume":"26","author":"Masone","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.nbd.2026.107506_bb0145","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1056\/NEJMoa0809716","article-title":"A novel protective prion protein variant that colocalizes with kuru exposure","volume":"361","author":"Mead","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2026.107506_bb0150","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1474-4422(22)00082-5","article-title":"Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt\u2013Jakob disease: evaluation of a first-in-human treatment programme","volume":"21","author":"Mead","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2026.107506_bb0155","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.coph.2018.12.005","article-title":"Identification of anti-prion drugs and targets using toxicity-based assays","volume":"44","author":"Mercer","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.nbd.2026.107506_bb0160","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1021\/acschemneuro.4c00095","article-title":"Sigma receptor ligands are potent antiprion compounds that act independently of sigma receptor binding","volume":"15","author":"Mercer","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.nbd.2026.107506_bb0165","first-page":"1","article-title":"Enhanced lysosomal activity prevents infection with PrPSc and the seeding activity of \u03b1-synuclein & tau prions","volume":"302","author":"Mercer","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2026.107506_bb0170","doi-asserted-by":"crossref","first-page":"10615","DOI":"10.1093\/nar\/gkaa616","article-title":"Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints","volume":"48","author":"Minikel","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2026.107506_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-84527-9","article-title":"Bank vole prion protein extends the use of RT-QuIC assays to detect prions in a range of inherited prion diseases","volume":"11","author":"Mok","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2026.107506_bb0180","doi-asserted-by":"crossref","first-page":"17610","DOI":"10.1073\/pnas.1009062107","article-title":"Pharmacological chaperone for the structured domain of human prion protein","volume":"107","author":"Nicoll","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2026.107506_bb0185","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1023\/A:1026315006619","article-title":"Prion protein is necessary for latent learning and long-term memory retention","volume":"17","author":"Nishida","year":"1997","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2026.107506_bb0190","article-title":"Bank vole prion protein as an apparently universal substrate for RT-QuIC-based detection and discrimination of prion strains","volume":"11","author":"Orr\u00fa","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.nbd.2026.107506_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012890","article-title":"Cofactors facilitate bona fide prion misfolding in vitro but are not necessary for the infectivity of recombinant murine prions","volume":"21","author":"P\u00e9rez-Castro","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.nbd.2026.107506_bb0200","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1073\/pnas.97.11.6073","article-title":"Mimicking dominant negative inhibition of prion replication through structure-based drug design","volume":"97","author":"Perrier","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2026.107506_bb0205","doi-asserted-by":"crossref","first-page":"13079","DOI":"10.1073\/pnas.182425299","article-title":"Dominant-negative inhibition of prion replication in transgenic mice","volume":"99","author":"Perrier","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2026.107506_bb0210","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1523\/JNEUROSCI.0409-08.2008","article-title":"Altered neuron excitability and synaptic plasticity in the cerebellar granular layer of juvenile prion protein knock-out mice with impaired motor control","volume":"28","author":"Prestori","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2026.107506_bb0215","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.nbd.2026.107506_bb0220","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Prusiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2026.107506_bb0225","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1073\/pnas.78.11.6675","article-title":"Scrapie agent contains a hydrophobic protein","volume":"78","author":"Prusiner","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2026.107506_bb0230","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1021\/acs.biochem.7b00894","article-title":"The G126V mutation in the mouse prion protein hinders nucleation-dependent fibril formation by slowing initial fibril growth and by increasing the critical concentration","volume":"56","author":"Sabareesan","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2026.107506_bb0235","doi-asserted-by":"crossref","first-page":"14789","DOI":"10.1021\/jacs.8b08311","article-title":"Direct observation of murine prion protein replication in vitro","volume":"140","author":"Sang","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.nbd.2026.107506_bb0240","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1038\/s41598-021-82647-w","article-title":"The G127V variant of the prion protein interferes with dimer formation in vitro but not in cellulo","volume":"11","author":"Sangeetham","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2026.107506_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/srep28711","article-title":"Application of an in vitro-amplification assay as a novel pre-screening test for compounds inhibiting the aggregation of prion protein scrapie","volume":"6","author":"Schmitz","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2026.107506_bb0250","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/PL00007415","article-title":"New haplotype of familial Creutzfeldt-Jakob disease with a codon 200 mutation and a codon 219 polymorphism of the prion protein gene in a Japanese family","volume":"99","author":"Seno","year":"2000","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2026.107506_bb0255","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ana.410430618","article-title":"Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease","volume":"43","author":"Shibuya","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2026.107506_bb0260","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.1021\/acsnano.2c12009","article-title":"Direct observation of competing prion protein fibril populations with distinct structures and kinetics","volume":"17","author":"Sun","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.nbd.2026.107506_bb0265","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1006\/jmbi.2000.3840","article-title":"Tetracycline affects abnormal properties of synthetic PrP peptides and PrPSc in vitro","volume":"300","author":"Tagliavini","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.nbd.2026.107506_bb0270","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/brain\/awl150","article-title":"A systematic review of prion therapeutics in experimental models","volume":"129","author":"Trevitt","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107506_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003990","article-title":"Evidence that bank vole PrP is a universal acceptor for prions","volume":"10","author":"Watts","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.nbd.2026.107506_bb0280","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nature01457","article-title":"Monoclonal antibodies inhibit prion replication and delay the development of prion disease","volume":"422","author":"White","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2026.107506_bb0285","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41551-019-0349-8","article-title":"A designer molecular chaperone against transmissible spongiform encephalopathy slows disease progression in mice and macaques","volume":"3","author":"Yamaguchi","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.nbd.2026.107506_bb0290","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31394-6","article-title":"Structural basis for the complete resistance of the human prion protein mutant G127V to prion disease","volume":"8","author":"Zheng","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2026.107506_bb0295","article-title":"Protective V127 prion variant prevents prion disease by interrupting the formation of dimer and fibril from molecular dynamics simulations","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126002512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126002512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:46:43Z","timestamp":1787582803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996126002512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":59,"alternative-id":["S0969996126002512"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107506","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leveraging the dominant-negative effect of the kuru-protective G127V prion protein variant as a novel therapeutic strategy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107506","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107506"}}